---
schema_version: "secwatch.filing_event.v1"
accession: "0000896264-25-000054"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T05:19:27.119975+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# USANA Q4 net sales -3% to $214M; net earnings -73% to $4.5M; FY2025 guidance includes Hiya

## Summary
- Q4 net sales $214M (-3% YoY); net earnings $4.5M (-73%); diluted EPS $0.23 (-74%).
- FY2024 net sales $855M (-7% YoY); net earnings $42M (-34%); diluted EPS $2.19.
- Active customers 454K (-6% YoY); Americas & Europe net sales +1% YoY, Asia Pacific -6%.
- Closed acquisition of 78.8% of Hiya on Dec 23, 2024; contributed ~$2M in Q4 sales.
- FY2025 outlook: net sales $920M–$1.0B; diluted EPS $1.50–$2.20; adjusted diluted EPS $2.35–$3.00.

## SEC filing metadata
- accession: 0000896264-25-000054
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000089626425000054/0000896264-25-000054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000089626425000054/usna-20250225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896264-25-000054
- JSON: https://secwatch.observer/filing/0000896264-25-000054.json
- Plain text: https://secwatch.observer/filing/0000896264-25-000054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.